检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:马亦林[1] Ma Yilin(Department of Infectious Diseases,State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China)
机构地区:[1]浙江大学医学院附属第一医院感染病科,传染病重症诊治全国重点实验室,国家感染性疾病临床医学研究中心,杭州310003
出 处:《中华临床感染病杂志》2024年第2期93-98,共6页Chinese Journal of Clinical Infectious Diseases
摘 要:乙型肝炎已成为严重威胁人类健康的世界性疾病,也是我国当前流行广泛、危害性严重的传染病之一。据《中国卫生健康统计年鉴(2022)》数据显示,2021年,我国乙型肝炎发病率为69.25人/10万人。为了使感染科临床工作者获得乙型肝炎研究的前沿信息,本文对乙型肝炎的靶点和新型诊断标志物与病毒复制的相关性、临床意义及检测技术改进等作了重点介绍,建议有条件单位逐步扩大检测,这将对临床诊断率及抗病毒药物评估有帮助,并有助于实现世界卫生组织提出“到2030年乙型肝炎诊断率要提升至90%”的目标。Hepatitis B has become a global disease that seriously threatens human health,and it is also one of the widespread and serous infectious diseases in China.According to China Health Statistical Yearbook(2022),the incidence rate of hepatitis B in China is 69.25/100000 in 2021.This article elaborates the the correlation between viral replication and related novel diagnostic markers of hepatitis virus,the clinical significance and the advances in detection technology of these markers,to provide information for clinician in the field of infectious diseases.It is suggested that the testing for novel hepatitis markers should be expanded in relevant institutions,which will be helpful for clinical diagnosis and antiviral therapy evaluation,to achieve the World Health Organization's goal of increasing hepatitis B diagnosis rate to 90%by 2030.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249